Informationen:
Fehler:
ID
42266
Beschreibung
Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin); ODM derived from: https://clinicaltrials.gov/show/NCT00890006
Link
https://clinicaltrials.gov/show/NCT00890006
Stichworte
Versionen (3)
- 13.05.17 13.05.17 -
- 10.04.21 10.04.21 - Ahmed Rafee, MD
- 26.04.21 26.04.21 - Sarah Riepenhausen
Rechteinhaber
MDM
Hochgeladen am
26. April 2021
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Low or Intermediate Risk Prostate Cancer NCT00890006
Eligibility Low or Intermediate Risk Prostate Cancer NCT00890006
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Low or Intermediate Risk Prostate Cancer NCT00890006
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
localized prostate cancer
Item
low or intermediate risk localized prostate cancer:
boolean
C0600139 (UMLS CUI [1])
gleason score
Item
gleason score ≤ 7
boolean
C0332326 (UMLS CUI [1])
psa
Item
psa <20
boolean
C0138741 (UMLS CUI [1])
prostate cancer stage
Item
stage t2a or less (stage 2 only)
boolean
C0280280 (UMLS CUI [1])
prostate cancer biopsy histology
Item
<50% of biopsy cores involved with tumor (stage 2 only)
boolean
C0600139 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,3])
C0005558 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,3])
hip replacement
Item
history of hip replacement
boolean
C0392806 (UMLS CUI [1])
inflammatory bowel disease, collagen vascular disease
Item
inflammatory bowel disease or collagen vascular disease
boolean
C0021390 (UMLS CUI [1])
C0262428 (UMLS CUI [2])
C0262428 (UMLS CUI [2])
fiducial markers contraindication
Item
contraindication to fiducial marker placement
boolean
C2826325 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
C1301624 (UMLS CUI [1,2])
bleeding diathesis, anticoagulant therapy
Item
bleeding diathesis or anticoagulant therapy that cannot safely be ceased temporarily
boolean
C0005779 (UMLS CUI [1])
C0150457 (UMLS CUI [2])
C0150457 (UMLS CUI [2])
trus- guided prostate biopsy adverse event
Item
severe adverse event with prior trus-guided prostate biopsy
boolean
C0194804 (UMLS CUI [1,1])
C0373345 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C0373345 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
patient refuses fiducial markers
Item
patient refuses fiducial marker placement
boolean
C2826325 (UMLS CUI [1,1])
C3242233 (UMLS CUI [1,2])
C3242233 (UMLS CUI [1,2])
mri contraindication
Item
contraindication to mri
boolean
C0024485 (UMLS CUI [1,1])
C0522473 (UMLS CUI [1,2])
C0522473 (UMLS CUI [1,2])
patient randomization
Item
patient randomization in profit trial (stage 2 only)
boolean
C0030705 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
C0034656 (UMLS CUI [1,2])
prostate radiotherapy
Item
patients not prescribed 78gy in 39 fractions to the prostate gland.
boolean
C0948317 (UMLS CUI [1])